Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash Provided by (Used in) Operating Activities
Net earnings	$ 1,121	$ 1,895
Adjustments to reconcile net earnings to operating cash flows:
Depreciation and amortization	53	53
Deferred income tax (benefit) provision	(72)	54
Earnings from equity investment in AB InBev	(86)	(342)
Loss on AB InBev/SABMiller business combination	0	33
Loss on Cronos-related financial instruments	425	0
Asset impairment and exit costs, net of cash paid	17	(7)
Cash effects of changes:
Receivables	(16)	9
Inventories	(25)	(30)
Accounts payable	(189)	(164)
Income taxes	471	521
Accrued liabilities and other current assets	(513)	(267)
Accrued settlement charges	913	1,018
Pension plan contributions	(3)	(7)
Pension provisions and postretirement, net	(8)	0
Other, net	201	43
Net cash provided by operating activities	2,289	2,809
Cash Provided by (Used in) Investing Activities
Capital expenditures	(38)	(34)
Investment in Cronos	(1,831)	0
Other, net	(81)	(7)
Net cash used in investing activities	(1,950)	(41)
Cash Provided by (Used in) Financing Activities
Repayment of short-term borrowings	(12,800)	0
Long-term debt issued	16,265	0
Repurchases of common stock	(151)	(513)
Dividends paid on common stock	(1,502)	(1,257)
Other	(129)	(23)
Net cash provided by (used in) financing activities	1,683	(1,793)
Cash, cash equivalents and restricted cash:
Increase (decrease)	2,022	975
Balance at beginning of period	1,433	1,314
Balance at end of period	3,455	2,289
Cash, cash equivalents and restricted cash	$ 1,433	$ 1,314